Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Pengana Capital Group Ltd. ( (AU:PCG) ) is now available.
Pengana Capital Group has filed a substantial holder notice in relation to its investment in Oncosil Medical Ltd. (ASX: OSL), updating the market on changes to its relevant interest and voting power in the company as at 19 March 2026. The filing, signed by Chief Operating Officer Keith McLachlan, details movements in Pengana’s holdings and any changes in associated entities, reflecting ongoing portfolio adjustments and governance engagement with Oncosil on behalf of Pengana’s investors.
While specific vote and share counts are contained in annexures, the notice confirms that Pengana remains a substantial holder and continues to actively manage its stake in Oncosil. Such changes in relevant interest are material for market participants monitoring ownership concentration, potential influence on corporate decisions, and the evolving relationship between Oncosil and one of its key institutional investors.
The most recent analyst rating on (AU:PCG) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Pengana Capital Group Ltd. stock, see the AU:PCG Stock Forecast page.
More about Pengana Capital Group Ltd.
Pengana Capital Group Ltd. is an Australian funds management company that acts as a substantial shareholder in listed entities, managing investment positions and associated voting rights on behalf of its investors. The firm focuses on active management and governance oversight through its holdings in companies such as Oncosil Medical Ltd., an ASX-listed medical business.
Average Trading Volume: 21,303
Technical Sentiment Signal: Sell
Current Market Cap: A$63.13M
See more insights into PCG stock on TipRanks’ Stock Analysis page.